Journal Article

PBMs Are at a Crossroads. Which Way Will They Go?

Trygstad, Troy

2024

Overview

During the 2010s, overall generic dispensing rates rose well into the 80%-plus range (up from 50%-plus roughly a decade prior), relegating drug cost control to intensive harvesting of savings from a small number of products or intensive reduction in dispensing rates for generics from pharmacies. SCRUTINY INTENSIFIES ON PBMS' BUSINESS PRACTICES AND BENEFIT TO THE MARKETPLACE In the summer of 2022, the Federal Trade Commission (FTC) launched an investigation into PBM practices,1 largely owing to these potential misalignments with purchasers and functional and efficient markets (thus the FTC on the inquiry's lead). The other half of the population entitled to government sponsored insurance will find local and national legislators and administrators demanding access to data to ensure their constituency doesn't wake up to see articles exposing gross excesses in economic rents from taxpayers.5 COMMUNITY PHARMACY SUSTAINABILITY AND SURVIVAL HANGS IN THE BALANCE Meanwhile, nearly 2500 pharmacies have closed in 2024 alone, with thousands more on the brink of closure due to paltry reimbursement and contract terms with PBMs.

• Publisher: Intellisphere, LLC,MultiMedia Healthcare Inc
• Subject: Drug stores / Financial services industry / Monoclonal antibodies / Pemetrexed / Pharmacists / Prescription drugs / Profits / Rate of return / Trospium